Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Research Institute of the McGill University Health Centre

$1,093,950.00

Epigenetic control of MYC-driven metabolic adaptations in aggressive prostate cancer

EF 2024-25

Résumé
Prostate cancer is the most prevalent cancer in men and a leading cause of cancer-related lethality. Consumption of saturated fat and obesity increase the risk of developing prostate cancer and related mortality, but the reasons for this association are still poorly understood. We have discovered that obesity from diets enriched in saturated fat directly affects the fuel and processes used by prostate cancer cells to thrive. This creates new molecular vulnerabilities that could be targeted as the Achilles' heel of prostate cancer to cripple disease progression. Here, we propose to use state-of-the-art models of prostate cancer and advanced biological techniques to strengthen our understanding of these molecular vulnerabilities and how they contribute to the progression of prostate cancer in the context of obesity and saturated fat diets. This work will provide a novel and much-needed framework to ultimately identify patients that may benefit from innovative therapeutic options, possibly combined with precision nutrition approaches, to fight this devastating disease.
Programme
Project Grant
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
522355
Name
Labbé David
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Epigenetic control of MYC-driven metabolic adaptations in aggressive prostate cancer
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$1,093,950
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer Biology; Diet; Epigenetics; Foxa1; Glycolysis; Metabolism; Mouse Models; Precision Nutrition; Prostate Cancer; Transcriptomics
Abstract
Prostate cancer is the most prevalent cancer in men and a leading cause of cancer-related lethality. Consumption of saturated fat and obesity increase the risk of developing prostate cancer and related mortality, but the reasons for this association are still poorly understood. We have discovered that obesity from diets enriched in saturated fat directly affects the fuel and processes used by prostate cancer cells to thrive. This creates new molecular vulnerabilities that could be targeted as the Achilles' heel of prostate cancer to cripple disease progression. Here, we propose to use state-of-the-art models of prostate cancer and advanced biological techniques to strengthen our understanding of these molecular vulnerabilities and how they contribute to the progression of prostate cancer in the context of obesity and saturated fat diets. This work will provide a novel and much-needed framework to ultimately identify patients that may benefit from innovative therapeutic options, possibly combined with precision nutrition approaches, to fight this devastating disease.
Competitiondate
202503
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Labbé, David
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,093,950~ $0~